ARCHIVES

NSABP’s Pink Sheet; Fisher’s Control Had A Downside, Review Said

This article is from The Cancer Letter archive.

Vol. 20 No. 25 | June 24, 1994

Download PDF Visit The Full Archive

Related Articles

In Brief: Recompetition Of Frederick Contract Flops, As Others Leave The Field To Litton-Bionetics

April 15, 1977

ODAC Chairman: Time Was Tight For Meeting

November 10, 1995

Atrix, Sanofi In Marketing Deal For Leuprogel Products.

January 26, 2001

NIOSH To Fund 21 Projects With NCI Money

February 25, 1977

NCAB Members Urge More Action In Support Of NCI.

December 15, 2006

Community Cancer Center Group Formed to Deal With “Toad-Like Pace Of NCI,” Other Problems

June 7, 1974